Titan Pharmaceuticals to Participate in RBC Capital Markets Global Healthcare Conference
SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 02/23/12 -- Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced that the company will participate in the RBC Capital Markets Global Healthcare Conference scheduled for February 28 and 29 in New York City. Titan's President, Sunil Bhonsle, will be part of a panel titled "New Developments in Neurology" on Tuesday, Feb. 28, 2012, at 2:35 p.m. EST at the New York Palace Hotel & Conference Center.
About Titan Pharmaceuticals
For information concerning Titan Pharmaceuticals, Inc., please visit the company's website at www.titanpharm.com.
The press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the Company's development program and any other statements that are not historical facts. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to difficulties or delays in development, testing, regulatory approval, production and marketing of the Company's drug candidates, adverse side effects or inadequate therapeutic efficacy of the Company's drug candidates that could slow or prevent product development or commercialization, the uncertainty of patent protection for the Company's intellectual property or trade secrets, and the Company's ability to obtain additional financing. Such statements are based on management's current expectations, but actual results may differ materially due to various factors, including those risks and uncertainties mentioned or referred to in this press release.
CONTACT: For Investors: Titan Pharmaceuticals, Inc. Sunil Bhonsle 650-244-4990 President For Media: Pure Communications Dan Budwick 973-271-6085 firstname.lastname@example.org
Source: Titan Pharmaceuticals, Inc.
Released February 23, 2012